Emerging Markets

 Spain announced that it imported a few doses of Mapp Biopharmaceutical’s ZMapp to treat a priest who was brought from Liberia to Madrid

Biopharma companies race to develop Ebola vaccine

By Zachary Brennan

As the death toll from the world’s most expansive Ebola outbreak nears 1,000, multiple companies are stepping up efforts to bring antibodies and other vaccines to human trials, though none seem likely to be ready until 2015 at the earliest.

Follow us

Products

View more

Webinars